Lv32
380 积分 2023-06-01 加入
GPCR drug discovery: new agents, targets and indications
26天前
已完结
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide
1个月前
已完结
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
Expression of Tissue Factor in Prostate Cancer Correlates With Malignant Phenotype
1个月前
已完结
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus
1个月前
已完结
Rheumatoid arthritis: advances in treatment strategies
3个月前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
4个月前
已完结
Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy
4个月前
已完结
Glue-based KRAS inhibitors make their debut cancer trial mark
5个月前
已完结
The PROTACtable genome
6个月前
已完结
皖公网安备34019202002308
